Académique Documents
Professionnel Documents
Culture Documents
193
Chapter 12
DRUGS USED IN ENDOCRINE
DISORDERS (HORMONES)
1. Which one of the following compounds
is not a hormone?
(a) Bromocriptine
(c) Somatotropin
(e) Vasopressin
(b) Somatomedin
(d) Thyroxine
Corticotropinreleasing hormone
Luteinizing hormone
Oxytocin
Thyrotropinreleasing hormone
Vasopressin
(a)
(b)
(c)
(d)
(e)
Bromocriptine
Desmopressin
Human gonadotropin hormone
Leuprolide
Octreotide
Corticotropin-releasing hormone
Cosyntropin
Gonadotropinreleasing hormone
Thyrotropinreleasing hormone
All of the above
MCQs IN PHARMACOLOGY
194
(c) Follicle-stimulating hormone (FSH)
(d) Thyroid-stimulating hormone (TSH)
(e) Adrenocorticotropic hormone (ACTH)
8. Which of the following drugs is least likely
to be used as part of a controlled ovarian
hyperstimulation protocol?
(a)
(b)
(c)
(d)
(e)
A flare of exophthalmos
Acute renal failure
Hemolysis
Overstimulation of the heart
Seizures
(b) Cortisol
(d) Ketoconazole
A disulfiram-like reaction
Excessive weight gain
Hypoglycemia
Lactic acidosis
Serious hepatotoxicity
(b) Colestipol
(d) Pioglitazone
(b) Glyburide
(d) Miglitol
195
(b) Has a longer half-life
(c) Has higher affinity for thyroid hormone
receptors
(d) Is faster acting
(e) Is more likely to improve a patients mood
23. A young woman seeks advice because she
had unprotected sexual intercourse 12
hours earlier. Based on her menstrual cycle,
she believes that conception is possible.
Which of the following drugs should she
use as a postcoital contraceptive?
(a)
(b)
(c)
(d)
(e)
Clompihene
Diethylstilbestrol plus raloxifene
Ethinyl estradiol combined with norethindrone
Flutamide
Letrozole plus finasteride
Ethinyl estradiol
Nonethindrone
Liothyronine
Prednisolone
Fluoxymesterone
(b) Clopidogrel
(d) Streptokinase
MCQs IN PHARMACOLOGY
196
27. A 42-year-old woman requires treatment
for diabetes insipidus following surgical
removal of part of her pituitary gland.
The advantage of treating this patient
with desmopressin instead of vasopressin
is that desmopressin
(a)
(b)
(c)
(d)
(e)
Somatotropin
Human Chorionic Gonadotropin (HCG)
Follicle-timulating hormone (FSH)
Thyroid-stimulating hormone (TSH)
Corticotropin (ACTH)
Corticosone
Hydrocorticosone
Prednisolone
Dextramethasone
Fludrocortisone
Progestins
Biguanides
-Glucosidase inhibitors
Thiourylenes
Sulfonylureas
T4
T3
T3
T4
T3
(b) Hydrocortisone
(d) Dexamethasone
(a)
(b)
(c)
(d)
(e)
Regular insulin
Isophane insulin (NPH)
Protamine zinc insulin (PZI)
Semilente insulin
Ultralente insulin
Graves disease
Hashimotos thyroiditis
Toxic multinodular goiter
Triiodothyronine tocicosis
Plummers disease
Endemic goiter
Surgical excision
Hashimotos thyroiditis
Goitrin-induced iodine deficiency
Gravess disease
43. Which of the following pairs of preparations has been studies for bioequivalence?
(a)
(b)
(c)
(d)
(e)
LevoxylThyrolar
Thyroglobulin - Proloid
Levothroid - Synthroid
Cytomel - Synthroid
Desiccated thyroidArmour thyroid
197
(d) Reverse triiodothyronine (rT3)
(e) Total thyroxine
45. Which of the following agents has been
shown to interact with oral thyroxine (T4)
replacement therapy?
(a) Propylthiouracil
(c) Thyrotropin
(e) Lovastatin
(b) Cholestyramine
(d) Levothyroxine
Hospitalized patients
Elderly patients with chronic disease
Elderly hospitalized patients
College students
Women over 20 years old
2550 g/day
50100 g/day
75150 g/day
100200 g/day
200400 g/day
MCQs IN PHARMACOLOGY
198
50. Which of the values represents the lower
level of detection for the fourth generation
sensitive TSH assay as established by the
Thyroid Association?
(a)
(b)
(c)
(d)
(e)
0.55 mlU/L
12 mlU/L
0.010.02 mlU/L
0.00010.002 mlU/L
0.00010.0002 mlU/L
Progestins
Biguanides
-Glucosides inhibitors
Thiourylenes
Sulfonylureas
Estradiol
Premarin
Theelin
Follicle-stimulating hormone
Stilbesterol
Derangement toxicosis
Hypothyroidism
Hypoparathyroidism
Hyperthyroidism
Thyroidits
(a)
(b)
(c)
(d)
(b) Supersensitivity
(d) Idiosyncrasy
Complete antigens
Haptenes
Antibodies
Mediators
Serum sickness
Anaphylactic shock
Systemic lupus erythematosus
Angioedema
Physical dependence
Psychological dependence
Both (a) and (b)
Psychiatric abnormality
Drug addiction
Drug abuse
Psychological dependence
Physical dependence
Renin
Angiotensin converting enzyme
Aminopeptidase
Angiotensinase
Direct vasoconstriction
Releasing adrenaline from adrenal medulla
Increasing central sympathetic tone
All of the above
(b) Angiotensin
(d) Plasmin
Hypercholesterolemia
Ventricular hypertrophy
Carbohydrate intolerance
Cardiac arrhythmia
Cyclic AMP
Cyclic GMP
Somatostatin
Insulin like growth factor 1
199
(a) Flutamide: Competitively blocks the binding
of androgens to their receptor
(b) Finasteride: Inhibits 5-reductase
(c) Miglitol: Inhibits -glucosidase
(d) Pioglitazone: Competitively blocks the
binding of estrogens to their receptor
(e) Anastrazole: Inhibits aromatase
70. The most prominent action of bromocriptine
is
(a)
(b)
(c)
(d)
Dopamine D2 agonism
Dopamine D2 antagonism
Dopamine D1 antagonism
adrenergic antagonism
Chlorpromazine
Cimetidine
Bromocriptine
Metoclopramide
Myxoedema
Graves disease
Carcinoma thyroid
Toxic nodular goiter
MCQs IN PHARMACOLOGY
200
(c) Finasteride : Benign prostatic hyperplasia
(d) Propylthiouracil: Hyperthyroidism
(e) Tamoxifen : Estrogen-dependent breast
cancer
(a) Brain
(c) Liver
(b) Heart
(d) Skeletal muscle
Endemic goiter
Cretinism
Papillary carcinoma of thyroid
Myxoedema coma
Iodide trapping
Oxidation of iodide
Proteolysis of thyroglobulin
Synthesis of thyroglobulin protein
(a)
(b)
(c)
(d)
Radioactive iodine
Lugols iodine
Propylthiouracil
Lithium carbonate
(b) Liver
(d) Kidney tubules
(b) Furosemide
(d) Amrinone
Cyproterone acetate
Danazol
Finasteride
Flutamide
201
(c) Osteoporosis
(d) Atrophic vaginitis
94. Addition of a progestin for 10-12 days
each month to estrogen replacement
therapy in menopausal women is
recommended because the progestin
(a) Blocks the increased risk of myocardial
infarction due to estrogen
(b) Blocks the increased risk of endometrial
carcinoma due to estrogen
(c) Reverses vulval atrophy occurring in
postmenopausal women
(d) Enhances the metabolic benefits of estrogen
treatment
95. The preferred estrogen for hormone replacement therapy in menopausal women is
(a)
(b)
(c)
(d)
Ethinylestradiol
Estradiol benzoate
Diethylstilbestrol
Conjugated estrogens
(b) Furosemide
(d) Amrinone
(b) Mifepristone
(d) Clomiphene citrate
MCQs IN PHARMACOLOGY
202
100. Insulin preparations that contain a modifying protein include
I. Lente insulin
II. Regular insulin
III. Isophane insulin (NPH)
(a) I only is correct
(b) III only is correct
(c) I and II are correct
(d) II and III are correct
(e) I, II and III are correct
101. Progesterone administration
(a)
(b)
(c)
(d)
Threatened abortion
Dysfunctional uterine bleeding
Hormone replacement therapy
Premenstrual tension
(b) Megestrol
(d) Tamoxifen
Endometriosis
Cushings syndrome
First term abortion
Second term abortion
(c) Danazol
(d) Medroxyprogesterone acetate
107. Which hormone is secreted by pancreatic
cells to facilitate glucose and amino acid
transport for normal cellular metabolic
processes ?
(a) Testosterone
(c) Corticotropin
(e) Vasopressin
(b) Insulin
(d) Estradiol
Glucose intolerance
Rise in blood pressure
Headache
Fluid retention
(b) Rifampicin
(d) Propranolol
(b) 46 months
(d) Uncertain period
(b) Insulin
(d) Estradiol
203
(a)
(b)
(c)
(d)
Cyproterone acetate
Goserelin
Centchroman
Gossypol
Myometrium
Myoepithelium of mammary alvioli
Vascular smooth muscle
Renal collecting ducts
Antithyroid agents
Sulfonylurea oral hypoglyccemics
Adrenocorticosteroids
Progestins
Androgens
Oxytocin
Methylergometrine
Dihydroergotamine
Prostaglandin E2
MCQs IN PHARMACOLOGY
204
125. The primary action of parathormone is
(a) To increase intestinal calcium absorption
(b) To increase calcium reabsorption in kidney
tubules
(c) To promote calcium deposition in extraosseus
tissues
(d) To increase resorption of calcium from bone
126. The drug of choice for hypoparathyroidism is
(a) Parathormone
(c) Vitamin D
(b) Cholecalciferol
(d) Calcitriol
(b) Vitamin C
(d) Vitamin A
(b) Phenylbutazone
(d) Ciprofloxacin
130. Estrogens
(a)
(b)
(c)
(d)
Antithyroid agents
Sulfonylurea oral hypoglyccemics
Adrenocorticosteroids
Progestins
Androgens
Mesterolone
Testosterone cypionate
Testosterone
Testosterone propionate
Prostatic carcinoma
Carcinoma of the breast in females
Promoting growth in hypogonadal children
Refractory anaemias associated with
hypoplastic bone marrow
205
(b) Pamidronate
(d) Vitamin D
(a)
(b)
(c)
(d)
(e)
Antithyroid agents
Sulfonylurea oral hypoglyccemics
Adrenocorticosteroids
Progestins
Androgens
ANSWERS
1. a
7. b
13. d
19. d
25. a
31. d
37. a
43. c
49. b
55. b
61. c
67. d
73. a
79. b
85. c
91. d
97. d
103. b
109. c
115. b
121. d
127. d
133. b
139. d
2. b
8. d
14. e
20. a
26. e
32. a
38. b
44. a
50. d
56. a
62. a
68. a
74. d
80. d
86. b
92. a
98. d
104. c
110. c
116. a
122. b
128. a
134. a
140. e
3. c
9. b
15. e
21. b
27. d
33. e
39. d
45. b
51. c
57. b
63. d
69. d
75. a
81. c
87. b
93. a
99. d
105. c
111. b
117. a
123. b
129. c
135. a
4. a
10. e
16. e
22. b
28. b
34. c
40. e
46. d
52. e
58. a
64. b
70. a
76. a
82. b
88. c
94. b
100. b
106. b
112. b
118. d
124. b
130. a
136. a
5. d
11. b
17. d
23. c
29. c
35. a
41. e
47. e
53. d
59. b
65. b
71. c
77. c
83. d
89.d
95. d
101. a
107. b
113. b
119. b
125. d
131. b
137. d
6. e
12. d
18. c
24. c
30. d
36. a
42. a
48. c
54. d
60. d
66. d
72. c
78. d
84. c
90. c
96. a
102. a
108. d
114. c
120. c
126. c
132. a
138. d
18. c
24. c
MCQs IN PHARMACOLOGY
206
30. d
37. a
49. b
52. e
69. d
75. a